Skip to main content
Livermore
Livermore
ZHEN

TD Private Client Wealth LLC

SEC CIK
0001551017
Latest filing
Aug 4, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by TD Private Client Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
8,359
Value
$400.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVO by TD Private Client Wealth LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,359$400.7K<0.1%+2,693+47.5%AddedHolders
Q1 20265,666$208.2K<0.1%−7,397−56.6%ReducedHolders
Q4 202513,063$664.6K<0.1%+6,343+94.4%AddedHolders
Q3 20256,720$372.9K<0.1%+4,140+160.5%AddedHolders
Q2 20252,580$178.1K<0.1%−331−11.4%ReducedHolders
Q1 20252,911$202.1K<0.1%−103−3.4%ReducedHolders
Q4 20243,014$259.3K<0.1%−1,544−33.9%ReducedHolders
Q3 20244,558$542.7K<0.1%−358−7.3%ReducedHolders
Q2 20244,916$701.7K<0.1%−2,240−31.3%ReducedHolders
Q1 20247,156$918.8K<0.1%−6,115−46.1%ReducedHolders
Q4 202313,271$1.37M<0.1%−3,032−18.6%ReducedHolders
Q3 202316,303$1.48M0.1%+1,781+12.3%AddedConverted for a 2-for-1 splitHolders
Q2 20237,261$1.18M0.1%+3,311+83.8%AddedHolders
Q1 20233,950$628.6K<0.1%−967−19.7%ReducedHolders
Q4 20224,917$665.5K<0.1%−143−2.8%ReducedHolders
Q3 20225,060$504.1K<0.1%−60−1.2%ReducedHolders
Q2 20225,120$570.5K<0.1%+2,423+89.8%AddedHolders
Q1 20222,697$299.5K<0.1%−462−14.6%ReducedHolders
Q4 20213,159$353.8K<0.1%+117+3.8%AddedHolders
Q3 20213,042$292.1K<0.1%+1,039+51.9%AddedHolders
Q2 20212,003$167.8K<0.1%−191−8.7%ReducedHolders
Q1 20212,194$147.9K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.